Cookies on this site

Carl Eiselen

BSc MD GDipSurgAnat


Clinical Research Fellow

  • Clinical Research Fellow, Interventional Genetics and Robotics for Retinal Disease (Kapetanovic Lab)
  • Honorary Clinical Research Fellow, Oxford University Hospitals NHS Foundation Trust
  • Sub-Investigator, Retinal Gene Therapy Trials (VISTA, LUNA and related programmes)
  • Sub-Investigator, Robotic Retinal Vein Cannulation Trial

Translational vitreoretinal surgeon-scientist integrating gene therapy, regenerative neurobiology and surgical robotics to treat blinding disease.

Biography

Carl Eiselen, BSc MD GDipSurgAnat, is a Clinical Research Fellow in Vitreoretinal Surgery at the Nuffield Department of Clinical Neurosciences, University of Oxford, working within the Kapetanovic Lab on gene therapy, surgical robotics, and translational retinal biology. He is an Honorary Clinical Research Fellow at Oxford University Hospitals and is pursuing academic training in regenerative ophthalmology and translational neurobiology.

Carl holds a First Class undergraduate degree from the University of Western Australia and a medical degree from the University of Melbourne. He completed postgraduate clinical training in neurosurgery and surgery, alongside research training at the University of Melbourne. He has published in clinical ophthalmology and translational neuroscience.

Raised in rural KwaZulu-Natal, South Africa, Carl grew up in a medical household where his father practised as a general practitioner and his mother managed the practice, serving an underserved community. Early exposure to front-line care and low-cost clinical innovation shaped his view that practical ingenuity can materially improve outcomes in resource-limited settings. This experience underpins his commitment to innovation that is both scientifically rigorous and socially equitable, particularly for populations historically underserved by advanced therapies.

Clinically, he works in complex medical and surgical retina, contributing to first-in-human and early-phase gene therapy trials and robotic-assisted microsurgical platforms. His work spans laboratory modelling, clinical trials, and device development, including contributions to retinal organoid platforms, axonal regeneration studies, and robotic retinal vein cannulation protocols.

His work is driven by a central question: how can neural function be restored in diseases once considered irreversibly degenerative, and how can such advances reach underserved populations? He focuses on integrating regenerative biology, gene therapy, and precision surgical systems to develop scalable treatments for neurological disease.

Collaborators

Recent publications

Asymptomatic bilateral acute multifocal retinitis in Q fever endocarditis.

Journal article

Eiselen C. et al, (2025), BMJ Case Rep, 18

Audit of enuresis referrals on the waiting list for a tertiary hospital outpatient clinic.

Journal article

Eiselen C. et al, (2021), J Paediatr Child Health, 57, 1645 - 1650

More publications